The Duality of Hydrogen Bonds in Drug Formulation
A new study in *Molecular Pharmaceutics* investigates the critical role of hydrogen bonding in the stability and performance of amorphous solid dispersions, a key formulation strategy for poorly soluble drugs. The research explores how the specific chemical nature of hydrogen-bond-donor groups on drug molecules influences their miscibility and interaction with polymer carriers. This molecular-level understanding is crucial for predicting physical stability, preventing crystallization, and ensuring consistent drug release, which directly impacts the bioavailability and therapeutic efficacy of oral medications.
Study Significance: For nephrology professionals managing patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD), this research has direct implications for medication safety and pharmacokinetics. Many commonly prescribed drugs have narrow therapeutic windows and are prone to nephrotoxicity; optimizing their formulation to ensure predictable absorption and minimize excipient-related kidney injury is a critical step in personalized pharmacotherapy. This work provides a molecular framework for designing safer, more effective oral dosage forms, which is essential for patients with compromised renal function and altered drug metabolism.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
